Irma Sanchez

Dedicated to exploring the nuances of cellular signaling, Irma Sanchez is an Associate Professor in the Department of Pathology at Perlmutter Cancer Center. Her research is at the forefront of understanding the subcellular mechanisms by which Mitogen-Activated Protein Kinases (MAPKs) transduce environmental extracellular signals. With a keen focus on the intricacies of signal transduction, she has made significant strides in uncovering the role of ERK3/MAPK6, a novel enzyme that plays a pivotal role in this process and is unique to vertebrates. Professor Sanchez employs a multidisciplinary approach, utilizing biochemical, cell biological, and molecular biological techniques to delve into the regulatory controls and cellular roles of ERK3. Her work is instrumental in elucidating the complex pathways of MAPK signaling, contributing to a deeper understanding of cancer biology and the potential for therapeutic interventions. Her research not only advances the scientific community's knowledge of subcellular mechanisms but also paves the way for innovative strategies in combating cancer. Her dedication to unraveling the complexities of ERK3 signaling has positioned her as a leading figure in the field, inspiring both her peers and students. Through her research, she continues to push the boundaries of what is known about MAPKs, offering new insights into their regulatory functions and their implications in disease. Her contributions are vital to the ongoing quest to decode the molecular underpinnings of cellular communication and its impact on human health.